Online mood monitoring in treatment-resistant depression: qualitative study of patients' perspectives in the NHS
- PMID: 31992374
- PMCID: PMC7283130
- DOI: 10.1192/bjb.2019.92
Online mood monitoring in treatment-resistant depression: qualitative study of patients' perspectives in the NHS
Abstract
Aims and method: True Colours is an automated symptom monitoring programme used by National Health Service psychiatric services. This study explored whether patients with unipolar treatment-resistant depression (TRD) found this a useful addition to their treatment regimes. Semi-structured qualitative interviews were conducted with 21 patients with TRD, who had engaged in True Colours monitoring as part of the Lithium versus Quetiapine in Depression study. A thematic analysis was used to assess participant experiences of the system.
Results: Six main themes emerged from the data, the most notable indicating that mood monitoring increased patients' insight into their disorder, but that subsequent behaviour change was absent.
Clinical implications: Patients with TRD can benefit from mood monitoring via True Colours, making it a worthwhile addition to treatment. Further development of such systems and additional support may be required for patients with TRD to experience further benefits as reported by other patient groups.
Keywords: Treatment-resistant depression; True Colours; major depression; mood monitoring; qualitative research.
Conflict of interest statement
References
-
- Fekadu A, Wooderson SC, Markopoulo K, Donaldson C, Papadopoulos A, Cleare AJ. What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies. J Affect Disord 2009; 116(1): 4–11. - PubMed
-
- Bipolar Disorder Research Network (BDRN).True Colours. BDRN, 2020. (http://bdrn.org/research/true-colours/).
Grants and funding
LinkOut - more resources
Full Text Sources